title: Familial myelodysplastic syndromes: a review of the literature.
abstract: Familial cases of myelodysplastic syndromes are rare, but are immensely valuable for the investigation of the molecular pathogenesis of myelodysplasia in general. The best-characterized familial myelodysplastic syndrome is that of familial platelet disorder with propensity to myeloid malignancy, caused by heterozygous germline RUNX1 mutations. Recently, there has been an increase in the number of reported cases, allowing for better understanding of the incidence, clinical features, and pathogenesis of this disorder. These recent cases have highlighted the clinical variability of the disorder and confirmed that many patients lack a bleeding and/or thrombocytopenia history. Additionally, several cases of T-acute lymphoblastic leukemia have now been reported, confirming a risk of lymphoid leukemia in patients with inherited RUNX1 mutations. Furthermore, an increased awareness of clinicians has helped detect a number of additional families affected by inherited myelodysplastic syndromes, resulting in the identification of novel causative mechanisms of disease, such as RUNX1 deficiency resulting from constitutional microdeletions of 21q22 and myelodysplasia-associated with telomerase deficiency. Awareness of predisposition to myelodysplastic syndromes and acute myeloid leukemia in families may be of critical importance in the management of younger patients with myelodysplasia in whom allogeneic hematopoietic stem cell transplantation is considered. Such families should be investigated for inherited deficiencies of RUNX1 and/or telomerase to prevent the use of an affected sibling as a donor for transplantation. Here we provide an update on familial platelet disorder in addition to a review of other known familial myelodysplastic syndromes.
authors: Division of Hematology and Hematologic Malignancies, Department of Medicine, University of Calgary, Calgary, AB, Canada.
authors: Elena
authors: E
authors: Liew
authors: Carolyn
authors: C
authors: Owen
references: Cancer. 1978 May;41(5):1959-63
references: 274171
references: Haematologica. 2006 May;91(5):707-8
references: 16670076
references: Lancet. 2003 Nov 15;362(9396):1628-30
references: 14630445
references: Leukemia. 1997 Dec;11(12):2111-9
references: 9447828
references: Blood. 2007 Jun 1;109(11):4641-7
references: 17299091
references: Blood. 2009 Nov 26;114(23):4761-70
references: 19745066
references: Genomics. 1992 Sep;14(1):121-5
references: 1358790
references: Leuk Res. 2010 Jan;34(1):e8-12
references: 19679353
references: Am J Med Genet A. 2010 Jul;152A(7):1711-7
references: 20578134
references: Clin Genet. 1995 Sep;48(3):140-7
references: 8556821
references: Leukemia. 2010 Jan;24(1):242-6
references: 19946261
references: Blood. 1996 Jun 15;87(12):5218-24
references: 8652836
references: Int J Hematol. 2010 Jul;92(1):194-7
references: 20549580
references: Leuk Lymphoma. 2004 Jan;45(1):1-10
references: 15061191
references: Blood. 2008 Dec 1;112(12):4639-45
references: 18723428
references: Blood. 2009 May 28;113(22):5583-7
references: 19357396
references: Cancer Genet Cytogenet. 2001 Jan 15;124(2):147-51
references: 11172908
references: Nature. 2001 Sep 27;413(6854):432-5
references: 11574891
references: Eur J Cancer. 1997 Apr;33(5):787-91
references: 9282118
references: Haematologica. 2007 Aug;92(8):1013-20
references: 17640862
references: Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):15960-4
references: 16247010
references: Blood. 2002 Feb 15;99(4):1364-72
references: 11830488
references: J Clin Invest. 1989 Sep;84(3):984-9
references: 2569483
references: Nat Genet. 2004 May;36(5):447-9
references: 15098033
references: Am J Med Genet A. 2010 Apr;152A(4):950-3
references: 20358607
references: Am J Med Genet A. 2011 Jan;155A(1):126-9
references: 21204219
references: EMBO J. 2007 Feb 21;26(4):1163-75
references: 17290219
references: Br J Haematol. 2002 Jun;117(4):878-81
references: 12060124
references: Blood. 2008 Aug 15;112(4):1042-7
references: 18487507
references: J Pediatr Hematol Oncol. 2010 Apr;32(3):195-228
references: 20186103
references: Eur J Hum Genet. 2008 Aug;16(8):1014-8
references: 18478040
references: Blood. 2010 Dec 23;116(26):6037-45
references: 20876458
references: Blood. 2005 Jun 15;105(12):4664-70
references: 15741216
references: N Engl J Med. 2009 Nov 5;361(19):1872-85
references: 19890130
references: Hum Mutat. 2009 Nov;30(11):1567-73
references: 19760749
references: Blood. 2001 Nov 1;98(9):2856-8
references: 11675361
references: Blood. 1985 Mar;65(3):557-63
references: 3855665
references: J Clin Oncol. 2011 Feb 10;29(5):504-15
references: 21220588
references: Blood. 2003 Aug 1;102(3):916-8
references: 12676774
references: Blood. 1995 Apr 15;85(8):1985-99
references: 7718870
references: Br J Haematol. 1991 Oct;79(2):246-55
references: 1958483
references: Am J Med Genet A. 2011 Jan;155A(1):120-5
references: 21204218
references: Br J Haematol. 2009 Apr;145(2):164-72
references: 19208095
references: Blood. 2009 Jun 25;113(26):6549-57
references: 19282459
references: Clin Genet. 2010 Feb;77(2):145-54
references: 19863549
references: Clin Genet. 1997 Feb;51(2):140-1
references: 9112010
references: Hematology Am Soc Hematol Educ Program. 2007;:29-39
references: 18024606
references: Blood. 2008 Jul 1;112(1):45-52
references: 18443215
references: Blood. 2004 Apr 1;103(7):2522-9
references: 14630789
references: Blood. 1999 Jul 15;94(2):803-7
references: 10397748
references: Cancer. 2007 Apr 15;109(8):1536-42
references: 17345612
references: J Pediatr Hematol Oncol. 2010 Aug;32(6):e236-7
references: 20661156
references: Blood. 2004 Feb 1;103(3):948-54
references: 14525764
references: Crit Rev Oncol Hematol. 2003 Feb;45(2):129-50
references: 12604126
references: Nat Genet. 1999 Oct;23(2):166-75
references: 10508512